Daniel Loeb’s Braskem BAK Stock Holding History

Daniel Loeb’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-100,000	Closed	-$2.6M	–	33
2018 Q2	$2.6M	Buy	+100,000	New	+$2.58M	0.02%	38

Other funds holding BAK

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CCM

Contrarian Capital Management Greenwich, Connecticut $306M AUM 23.06% 1-Year Est. Return

Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Daniel Loeb's BAK Position: Q3 2018 in Review

Daniel Loeb sold out of Braskem (BAK) in Q3 2018, closing a stake of 100,000 shares — an estimated $2.6M sold.

Daniel Loeb first reported a position in BAK in Q2 2018 and held it in 1 quarter. The position peaked at $2.6M in Q2 2018. 93 funds tracked by Wall St. Rank hold BAK as of Q3 2018.

Daniel Loeb reported no remaining Braskem position as of Q3 2018 after selling out during the quarter.
Daniel Loeb sold 100,000 Braskem shares in Q3 2018, an estimated $2.6M.
Daniel Loeb first reported a position in Braskem in Q2 2018 and held it in 1 quarter.
Daniel Loeb's Braskem position peaked at $2.6M in Q2 2018.
93 funds tracked by Wall St. Rank held Braskem as of Q3 2018.

Based on Third Point's 13F filing for Q3 2018, filed 9 Nov 2018.